GLP-1 Drugs Show Broad Organ Protection Beyond Diabetes Control
The expanding therapeutic reach of GLP-1 medications signals a potential shift from single-target treatments to multi-organ protective therapies. What began as…
Found 150 results for "sleep"
The expanding therapeutic reach of GLP-1 medications signals a potential shift from single-target treatments to multi-organ protective therapies. What began as…
The trajectory of adolescent brain injury recovery reveals a more complex interplay between sleep and mental health than previously understood, with implicatio…
The decades-long debate over daylight saving time's health impact gains crucial nuance from the most comprehensive analysis to date, challenging the prevailing…
The persistent anxiety that often accompanies aging may finally have a clear neurobiological explanation, offering new therapeutic targets for millions of olde…
Sleep disorders following traumatic brain injury represent a critical yet underserved healthcare challenge, particularly within military populations where trad…
The persistence of preventable infant deaths highlights a critical gap between regulatory action and real-world safety outcomes. Despite federal recalls target…
Heart attack timing could determine survival odds, with emerging evidence pointing to our internal biological clocks as the decisive factor. This discovery ope…
The regulatory shift removing black box warnings from menopausal hormone therapy creates unprecedented opportunities for breast cancer survivors facing severe…
The My Heart Counts study launches a comprehensive digital cardiovascular health investigation targeting 15,000 adults across the US and UK. Participants will…
The rise of conversational AI presents an unexpected mental health concern that extends far beyond typical digital wellness discussions. As millions engage wit…
Breast cancer's ability to resurface years after treatment has puzzled oncologists and terrified survivors. This discovery reveals a fundamental mechanism cont…
The biological clocks ticking inside our cells may serve as early warning systems for Alzheimer's disease, potentially offering a new window into neurodegenera…
Contactless under-mattress sensors successfully predicted next-day agitation episodes in dementia patients across 73 individuals and over 1,100 nights of monit…
The growing popularity of intermittent fasting approaches may come with an unexpected cost to sleep quality and duration. This comprehensive analysis challenge…
Sleep disorders may represent one of the most underappreciated cardiovascular risk factors in military populations, with implications extending far beyond tire…
Phase 3 trials demonstrate that GLP-1 receptor agonists like semaglutide and tirzepatide produce sustained 10-20% weight loss in women aged 65 and older, along…
Analysis of all 50 U.S. states reveals a statistically significant correlation between the number of extreme heat days per year and population-level prevalence…
A noninvasive respiratory volume monitor successfully identified dangerous drops in breathing (minute ventilation below 40%) in 62% of children recovering from…
Clinical evidence reveals semaglutide's therapeutic effects extend far beyond its original diabetes indication, with documented benefits across cardiovascular…